Highlight of 2023: CAR T cells driving precision therapy for autoimmune disease.

Published in: Immunology and cell biology (2024)

CAR T cell therapy is showing remarkable results in autoimmune disease with treatment-refractory patients showing durable drug-free remission. Here, we highlight five key papers from 2023 that are driving the development of CAR T cells to improve precision, safety, efficacy and accessibility for the treatment of autoantibody-associated autoimmune diseases.

Keyphrases

cell therapy
end stage renal disease
multiple sclerosis
newly diagnosed
chronic kidney disease
stem cells
mesenchymal stem cells
drug induced
peritoneal dialysis
combination therapy
disease activity